Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
REXO1 like 1, pseudogene | 0.792 | 0.077 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 1996 | 2007 | |||||||||
|
RNA polymerase II subunit L | 1.000 | 0.077 | 4.5E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
EF-hand calcium binding domain 14 | 1.000 | 0.077 | 7.8E-08 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
keratin 23 | 0.716 | 0.154 | 4.7E-13 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
zinc finger protein 354C | 0.861 | 0.154 | 4.1E-10 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
interferon alpha 4 | 0.861 | 0.154 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | |||||||||
|
chromosome 20 open reading frame 194 | 0.861 | 0.192 | 1.1E-12 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2012 | 2012 | ||||||||
|
CYCS pseudogene 25 | 0.780 | 0.231 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | |||||||||
|
phosphomannomutase 1 | 0.861 | 0.231 | 1.7E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
polypeptide N-acetylgalactosaminyltransferase 8 | 0.861 | 0.269 | 8.1E-20 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
DDRGK domain containing 1 | 0.736 | 0.269 | 3.1E-07 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
cytochrome b reductase 1 | 0.729 | 0.269 | 1.2E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
ring finger protein 7 | 0.716 | 0.308 | 3.3E-02 |
|
disease | 0.020 | None | 1.000 | 2 | 1 | 2016 | 2017 | ||||||||
|
MAPK activated protein kinase 3 | 0.743 | 0.308 | 3.7E-09 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
tripartite motif containing 5 | 0.700 | 0.385 | 6.0E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
solute carrier family 28 member 2 | 0.780 | 0.385 | 1.1E-27 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
perilipin 3 | 0.736 | 0.423 | 1.2E-07 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
suppressor of cytokine signaling 7 | 0.736 | 0.423 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2013 | 2013 | ||||||||
|
TATA-box binding protein like 2 | 0.700 | 0.423 | 1.5E-10 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
thyroid carcinoma, Hurthle cell | 0.644 | 0.423 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
BOC cell adhesion associated, oncogene regulated | 0.666 | 0.423 | 1.7E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
transmembrane 6 superfamily member 2 | 0.638 | 0.462 | 3.6E-05 |
|
disease | 0.060 | None | 0.833 | 6 | 1 | 2015 | 2018 | ||||||||
|
interferon induced protein 35 | 0.760 | 0.462 | 4.3E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
H3 histone pseudogene 44 | 0.636 | 0.462 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | |||||||||
|
proteasome 26S subunit, non-ATPase 3 | 0.751 | 0.462 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 |